Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Cash Flow-to-Debt Ratio
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Cash Flow-to-Debt Ratio of 0.14x as of September 2025, meaning its operating cash flow of CN¥1.25 Billion could theoretically repay 0% of its total liabilities (CN¥8.77 Billion) in one year. See 600866 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Starlake Bioscience Co Inc Zhaoqing Guangdong across 28 annual periods. For the full cash flow conversion analysis, see 600866 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year debt coverage analysis for Starlake Bioscience Co Inc Zhaoqing Guangdong. Check how high is Starlake Bioscience Co Inc Zhaoqing Guan's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥1.29 Billion | CN¥8.79 Billion | ▼ -60.0% |
| 2024 | 0.37x | CN¥2.40 Billion | CN¥6.52 Billion | ▲ +22.1% |
| 2023 | 0.30x | CN¥2.03 Billion | CN¥6.73 Billion | ▲ +64.3% |
| 2022 | 0.18x | CN¥1.66 Billion | CN¥9.07 Billion | ▼ -33.6% |
| 2021 | 0.28x | CN¥192.63 Million | CN¥697.74 Million | ▼ -16.8% |
| 2020 | 0.33x | CN¥249.99 Million | CN¥752.97 Million | ▼ -7.2% |
| 2019 | 0.36x | CN¥213.17 Million | CN¥595.95 Million | ▲ +245.0% |
| 2018 | 0.10x | CN¥50.69 Million | CN¥488.94 Million | ▲ +38.4% |
| 2017 | 0.07x | CN¥40.05 Million | CN¥534.57 Million | ▲ +16.1% |
| 2016 | 0.06x | CN¥41.17 Million | CN¥637.90 Million | ▲ +1771.0% |
| 2015 | 0.00x | CN¥2.75 Million | CN¥795.88 Million | ▲ +113.4% |
| 2014 | -0.03x | CN¥-20.22 Million | CN¥787.37 Million | ▼ -3.8% |
| 2013 | -0.02x | CN¥-28.16 Million | CN¥1.14 Billion | ▲ +84.8% |
| 2012 | -0.16x | CN¥-276.02 Million | CN¥1.70 Billion | ▼ -499.7% |
| 2011 | 0.04x | CN¥65.88 Million | CN¥1.62 Billion | ▼ -72.9% |
| 2010 | 0.15x | CN¥104.63 Million | CN¥698.07 Million | ▼ -77.4% |
| 2009 | 0.66x | CN¥316.73 Million | CN¥477.36 Million | ▲ +158.6% |
| 2008 | 0.26x | CN¥148.93 Million | CN¥580.44 Million | ▲ +89.4% |
| 2007 | 0.14x | CN¥82.28 Million | CN¥607.29 Million | ▲ +99.3% |
| 2006 | 0.07x | CN¥35.14 Million | CN¥516.89 Million | ▼ -28.9% |
| 2005 | 0.10x | CN¥46.83 Million | CN¥489.57 Million | ▲ +35.3% |
| 2004 | 0.07x | CN¥29.05 Million | CN¥410.86 Million | ▼ -87.4% |
| 2003 | 0.56x | CN¥149.70 Million | CN¥266.82 Million | ▼ -42.1% |
| 2002 | 0.97x | CN¥183.18 Million | CN¥188.89 Million | ▲ +292.2% |
| 2001 | 0.25x | CN¥60.82 Million | CN¥245.97 Million | ▼ -12.2% |
| 2000 | 0.28x | CN¥93.41 Million | CN¥331.53 Million | ▼ -23.5% |
| 1999 | 0.37x | CN¥52.97 Million | CN¥143.87 Million | ▼ -14.3% |
| 1998 | 0.43x | CN¥71.14 Million | CN¥165.54 Million | — |